Ethanolamine Utilization and Bacterial Microcompartment Formation Are Subject to Carbon Catabolite Repression

Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regula...

Full description

Saved in:
Bibliographic Details
Published inJournal of bacteriology Vol. 201; no. 10; p. 1
Main Authors Kaval, Karan Gautam, Gebbie, Margo, Goodson, Jonathan R., Cruz, Melissa R., Winkler, Wade C., Garsin, Danielle A.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 15.05.2019
Subjects
Online AccessGet full text
ISSN0021-9193
1098-5530
1098-5530
DOI10.1128/JB.00703-18

Cover

Abstract Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis , a GI commensal and opportunistic pathogen, contains approximately 20 e thanolamine ut ilization ( eut ) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic b acterial m icro c ompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS , was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR). IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.
AbstractList Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. , a GI commensal and opportunistic pathogen, contains approximately 20 thanolamine ilization ( ) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in gene expression, was a concomitant increase in the number of catabolic acterial icro ompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted site in one of the three EA-inducible promoters, , was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR). Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as and Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.
Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria. Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis , a GI commensal and opportunistic pathogen, contains approximately 20 e thanolamine ut ilization ( eut ) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic b acterial m icro c ompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS , was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR). IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella . Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.
Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).IMPORTANCE Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize it, such as Enterococcus faecalis and Salmonella Therefore, it is important to understand how the genes that govern EA utilization are regulated. In this work, we investigated two regulatory factors that control this process. One factor, a small RNA (sRNA), is shown to be important for generating the right levels of gene expression for maximum efficiency. The second factor, a transcriptional repressor, is important for preventing expression when other preferred sources of energy are available. Furthermore, a global bioinformatics analysis revealed that this second mechanism of transcriptional regulation likely operates on similar genes in related bacteria.
Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus faecalis, a GI commensal and opportunistic pathogen, contains approximately 20 ethanolamine utilization (eut) genes encoding the necessary regulatory, enzymatic, and structural proteins for this process. Here, using a chemically defined medium, two regulatory factors that affect EA utilization were examined. First, the functional consequences of loss of the small RNA (sRNA) EutX on the efficacy of EA utilization were investigated. One effect observed, as loss of this negative regulator causes an increase in eut gene expression, was a concomitant increase in the number of catabolic bacterial microcompartments (BMCs) formed. However, despite this increase, the growth of the strain was repressed, suggesting that the overall efficacy of EA utilization was negatively affected. Second, utilizing a deletion mutant and a complement, carbon catabolite control protein A (CcpA) was shown to be responsible for the repression of EA utilization in the presence of glucose. A predicted cre site in one of the three EA-inducible promoters, PeutS, was identified as the target of CcpA. However, CcpA was shown to affect the activation of all the promoters indirectly through the two-component system EutV and EutW, whose genes are under the control of the PeutS promoter. Moreover, a bioinformatics analysis of bacteria predicted to contain CcpA and cre sites revealed that a preponderance of BMC-containing operons are likely regulated by carbon catabolite repression (CCR).
Author Cruz, Melissa R.
Goodson, Jonathan R.
Kaval, Karan Gautam
Winkler, Wade C.
Garsin, Danielle A.
Gebbie, Margo
Author_xml – sequence: 1
  givenname: Karan Gautam
  surname: Kaval
  fullname: Kaval, Karan Gautam
  organization: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA
– sequence: 2
  givenname: Margo
  surname: Gebbie
  fullname: Gebbie, Margo
  organization: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA
– sequence: 3
  givenname: Jonathan R.
  surname: Goodson
  fullname: Goodson, Jonathan R.
  organization: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA
– sequence: 4
  givenname: Melissa R.
  surname: Cruz
  fullname: Cruz, Melissa R.
  organization: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA
– sequence: 5
  givenname: Wade C.
  surname: Winkler
  fullname: Winkler, Wade C.
  organization: Department of Cell Biology and Molecular Genetics, University of Maryland, College Park, Maryland, USA
– sequence: 6
  givenname: Danielle A.
  surname: Garsin
  fullname: Garsin, Danielle A.
  organization: Department of Microbiology and Molecular Genetics, The University of Texas Health Science Center at Houston, Houston, Texas, USA, The UT Center for Antimicrobial Resistance and Genomics, The University of Texas Health Science Center at Houston, Houston, Texas, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/30833356$$D View this record in MEDLINE/PubMed
BookMark eNptkcFrFDEUh4NU7LZ68i4BL4JMfUkms5mL0F1aa6kIas8hk3ljs8wka5IR9K837bbFlp4CyZcfv_e-A7Lng0dCXjM4YoyrD-erI4AliIqpZ2TBoFWVlAL2yAKAs6plrdgnByltAFhdS_6C7AtQQgjZLMh0kq-MD6OZnEd6md3o_prsgqfG93RlbMbozEi_OBuDDdPWxDyhz_Q0xGkHHkek3-dugzbTHOjaxK7crk02XRhdRvoNtxFTKuxL8nwwY8JXt-chuTw9-bE-qy6-fvq8Pr6obA1trlpuRdv2sjTvhVRKSVQCDWskwDBwOYDs0TLeiKYHpRiKxgK03cCWdT00gzgkH3e527mbsLelcDSj3kY3mfhHB-P0wxfvrvTP8Fs3teItX5aAd7cBMfyaMWU9uWRxHI3HMCfNmVIclrW8Rt8-Qjdhjr6MpzkXHIobLgr15v9G91XuTBTg_Q4oe04p4nCPMNDXnvX5St941kwVmj2ircs3Oso4bnzyzz-zBqqo
CitedBy_id crossref_primary_10_1016_j_crmicr_2022_100157
crossref_primary_10_1128_mbio_01216_23
crossref_primary_10_1016_j_mib_2021_04_008
crossref_primary_10_1111_mmi_14962
crossref_primary_10_1128_mBio_00380_21
crossref_primary_10_1128_msystems_01349_20
crossref_primary_10_1128_IAI_00270_20
crossref_primary_10_3390_medsci10030040
crossref_primary_10_1128_ecosalplus_esp_0025_2019
crossref_primary_10_1128_jb_00047_22
crossref_primary_10_1128_msystems_00750_24
crossref_primary_10_1128_jb_00269_24
Cites_doi 10.1128/JB.00838-09
10.1186/1471-2180-10-224
10.1016/0005-2760(69)90030-7
10.1128/JB.00217-11
10.1073/pnas.1107857108
10.1038/nrmicro2334
10.1128/jb.174.20.6634-6643.1992
10.1093/nar/gkp335
10.1126/science.1258494
10.1007/978-1-60761-854-6_5
10.1128/JB.00706-13
10.1128/JB.182.20.5799-5806.2000
10.1074/jbc.M202573200
10.1371/journal.pgen.1002666
10.1073/pnas.0812194106
10.1038/nrmicro.2018.10
10.1002/9780471729259.mc09d02s30
10.1128/JB.00952-08
10.1146/annurev.micro.50.1.137
10.1186/1471-2164-13-401
10.1016/j.mib.2015.12.006
10.1111/j.1462-2920.2010.02334.x
10.1128/jb.170.2.700-707.1988
10.1126/science.1255083
10.3389/fcimb.2016.00158
10.1128/jb.175.16.5216-5223.1993
10.1093/bioinformatics/btr064
10.1042/bj1760751
10.1126/science.1255091
10.1128/jb.176.15.4527-4533.1994
10.1042/bst0040495
10.1111/mmi.12537
10.1271/bbb.80479
10.1128/mBio.00066-18
10.1093/nar/gks864
10.1099/00222615-34-3-143
10.1016/j.plasmid.2006.08.003
10.1371/journal.pcbi.1003898
10.1128/mBio.00414-18
ContentType Journal Article
Copyright Copyright © 2019 American Society for Microbiology.
Copyright American Society for Microbiology May 2019
Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology
Copyright_xml – notice: Copyright © 2019 American Society for Microbiology.
– notice: Copyright American Society for Microbiology May 2019
– notice: Copyright © 2019 American Society for Microbiology. 2019 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7QL
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
DOI 10.1128/JB.00703-18
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
Bacteriology Abstracts (Microbiology B)
Nucleic Acids Abstracts
Virology and AIDS Abstracts
Technology Research Database
Environmental Sciences and Pollution Management
Engineering Research Database
AIDS and Cancer Research Abstracts
Algology Mycology and Protozoology Abstracts (Microbiology C)
Biotechnology and BioEngineering Abstracts
Genetics Abstracts
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
Genetics Abstracts
Virology and AIDS Abstracts
Technology Research Database
Bacteriology Abstracts (Microbiology B)
Algology Mycology and Protozoology Abstracts (Microbiology C)
Nucleic Acids Abstracts
AIDS and Cancer Research Abstracts
Engineering Research Database
Biotechnology and BioEngineering Abstracts
Environmental Sciences and Pollution Management
MEDLINE - Academic
DatabaseTitleList MEDLINE

MEDLINE - Academic
CrossRef
Genetics Abstracts
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Catabolite Repression of Ethanolamine Utilization
EISSN 1098-5530
ExternalDocumentID PMC6482927
30833356
10_1128_JB_00703_18
Genre Journal Article
Research Support, N.I.H., Extramural
GrantInformation_xml – fundername: NIAID NIH HHS
  grantid: R01 AI110432
– fundername: ;
  grantid: R01AI110432
GroupedDBID ---
-DZ
-~X
.55
0R~
18M
29J
2WC
39C
4.4
53G
5GY
5RE
5VS
79B
85S
AAGFI
AAYXX
ABPPZ
ACGFO
ACGOD
ACNCT
ACPRK
ADBBV
AENEX
AFRAH
AGVNZ
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BKOMP
BTFSW
CITATION
CJ0
CS3
DIK
DU5
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
L7B
O9-
OK1
P-S
P2P
PQQKQ
RHI
RNS
RPM
RSF
RXW
TAE
TR2
UHB
UKR
UPT
W8F
WH7
WOQ
X7M
YQT
YR2
YZZ
ZCA
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
RHF
UCJ
VQA
YIN
7QL
7TM
7U9
8FD
C1K
FR3
H94
M7N
P64
RC3
7X8
5PM
ID FETCH-LOGICAL-c409t-92c399d5193d358885e83ea16500ff25f05dec12636d0881e36c009bf1744f6f3
ISSN 0021-9193
1098-5530
IngestDate Thu Aug 21 18:33:09 EDT 2025
Thu Sep 04 14:27:48 EDT 2025
Mon Jun 30 10:32:46 EDT 2025
Wed Feb 19 02:31:06 EST 2025
Tue Jul 01 02:56:29 EDT 2025
Thu Apr 24 22:52:34 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 10
Keywords carbon catabolite repression
bacterial microcompartments
ethanolamine utilization
enterococcus
Language English
License Copyright © 2019 American Society for Microbiology.
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c409t-92c399d5193d358885e83ea16500ff25f05dec12636d0881e36c009bf1744f6f3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
K.G.K. and M.G. contributed equally to this work.
Citation Kaval KG, Gebbie M, Goodson JR, Cruz MR, Winkler WC, Garsin DA. 2019. Ethanolamine utilization and bacterial microcompartment formation are subject to carbon catabolite repression. J Bacteriol 201:e00703-18. https://doi.org/10.1128/JB.00703-18.
OpenAccessLink https://jb.asm.org/content/jb/201/10/e00703-18.full.pdf
PMID 30833356
PQID 2232000723
PQPubID 40724
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_6482927
proquest_miscellaneous_2188207457
proquest_journals_2232000723
pubmed_primary_30833356
crossref_primary_10_1128_JB_00703_18
crossref_citationtrail_10_1128_JB_00703_18
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2019-05-15
PublicationDateYYYYMMDD 2019-05-15
PublicationDate_xml – month: 05
  year: 2019
  text: 2019-05-15
  day: 15
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: Washington
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of bacteriology
PublicationTitleAlternate J Bacteriol
PublicationYear 2019
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References White DA (e_1_3_3_5_2) 1973
DebRoy S (e_1_3_3_16_2) 2014
e_1_3_3_17_2
e_1_3_3_19_2
e_1_3_3_38_2
e_1_3_3_18_2
e_1_3_3_39_2
e_1_3_3_13_2
e_1_3_3_36_2
e_1_3_3_12_2
e_1_3_3_37_2
e_1_3_3_15_2
e_1_3_3_34_2
e_1_3_3_14_2
e_1_3_3_35_2
e_1_3_3_32_2
e_1_3_3_33_2
e_1_3_3_11_2
e_1_3_3_30_2
e_1_3_3_10_2
e_1_3_3_31_2
e_1_3_3_40_2
Ramsey M (e_1_3_3_26_2) 2014
e_1_3_3_6_2
e_1_3_3_8_2
e_1_3_3_7_2
e_1_3_3_28_2
e_1_3_3_9_2
e_1_3_3_27_2
e_1_3_3_29_2
e_1_3_3_24_2
e_1_3_3_23_2
e_1_3_3_25_2
e_1_3_3_2_2
e_1_3_3_20_2
e_1_3_3_43_2
e_1_3_3_4_2
e_1_3_3_22_2
e_1_3_3_41_2
e_1_3_3_3_2
e_1_3_3_21_2
e_1_3_3_42_2
References_xml – ident: e_1_3_3_2_2
  doi: 10.1128/JB.00838-09
– ident: e_1_3_3_30_2
  doi: 10.1186/1471-2180-10-224
– ident: e_1_3_3_4_2
  doi: 10.1016/0005-2760(69)90030-7
– ident: e_1_3_3_20_2
  doi: 10.1128/JB.00217-11
– ident: e_1_3_3_7_2
  doi: 10.1073/pnas.1107857108
– ident: e_1_3_3_10_2
  doi: 10.1038/nrmicro2334
– ident: e_1_3_3_19_2
  doi: 10.1128/jb.174.20.6634-6643.1992
– volume-title: Enterococci: from commensals to leading causes of drug resistant infection
  year: 2014
  ident: e_1_3_3_16_2
– ident: e_1_3_3_40_2
  doi: 10.1093/nar/gkp335
– ident: e_1_3_3_12_2
  doi: 10.1126/science.1258494
– ident: e_1_3_3_43_2
  doi: 10.1007/978-1-60761-854-6_5
– volume-title: Enterococci: from commensals to leading causes of drug resistant infection
  year: 2014
  ident: e_1_3_3_26_2
– ident: e_1_3_3_28_2
  doi: 10.1128/JB.00706-13
– ident: e_1_3_3_29_2
  doi: 10.1128/JB.182.20.5799-5806.2000
– ident: e_1_3_3_24_2
  doi: 10.1074/jbc.M202573200
– ident: e_1_3_3_11_2
  doi: 10.1371/journal.pgen.1002666
– ident: e_1_3_3_9_2
  doi: 10.1073/pnas.0812194106
– ident: e_1_3_3_27_2
  doi: 10.1038/nrmicro.2018.10
– start-page: 441
  volume-title: Form and function of phospholipids
  year: 1973
  ident: e_1_3_3_5_2
– ident: e_1_3_3_35_2
  doi: 10.1002/9780471729259.mc09d02s30
– ident: e_1_3_3_8_2
  doi: 10.1128/JB.00952-08
– ident: e_1_3_3_34_2
  doi: 10.1146/annurev.micro.50.1.137
– ident: e_1_3_3_41_2
  doi: 10.1186/1471-2164-13-401
– ident: e_1_3_3_13_2
  doi: 10.1016/j.mib.2015.12.006
– ident: e_1_3_3_6_2
  doi: 10.1111/j.1462-2920.2010.02334.x
– ident: e_1_3_3_25_2
  doi: 10.1128/jb.170.2.700-707.1988
– ident: e_1_3_3_15_2
  doi: 10.1126/science.1255083
– ident: e_1_3_3_22_2
  doi: 10.3389/fcimb.2016.00158
– ident: e_1_3_3_36_2
  doi: 10.1128/jb.175.16.5216-5223.1993
– ident: e_1_3_3_42_2
  doi: 10.1093/bioinformatics/btr064
– ident: e_1_3_3_18_2
  doi: 10.1042/bj1760751
– ident: e_1_3_3_14_2
  doi: 10.1126/science.1255091
– ident: e_1_3_3_21_2
  doi: 10.1128/jb.176.15.4527-4533.1994
– ident: e_1_3_3_17_2
  doi: 10.1042/bst0040495
– ident: e_1_3_3_32_2
  doi: 10.1111/mmi.12537
– ident: e_1_3_3_37_2
  doi: 10.1271/bbb.80479
– ident: e_1_3_3_3_2
  doi: 10.1128/mBio.00066-18
– ident: e_1_3_3_31_2
  doi: 10.1093/nar/gks864
– ident: e_1_3_3_23_2
  doi: 10.1099/00222615-34-3-143
– ident: e_1_3_3_38_2
  doi: 10.1016/j.plasmid.2006.08.003
– ident: e_1_3_3_33_2
  doi: 10.1371/journal.pcbi.1003898
– ident: e_1_3_3_39_2
  doi: 10.1128/mBio.00414-18
SSID ssj0014452
Score 2.383193
Snippet Ethanolamine (EA) is a compound commonly found in the gastrointestinal (GI) tract that can affect the behavior of human pathogens that can sense and utilize...
Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. , a GI commensal and...
Ethanolamine (EA) is a compound prevalent in the gastrointestinal (GI) tract that can be used as a carbon, nitrogen, and/or energy source. Enterococcus...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 1
SubjectTerms Bacteria
Bacteriology
Bioinformatics
Carbon
Catabolite Repression
Culture Media - chemistry
Deletion mutant
Energy sources
Enterococcus faecalis - genetics
Enterococcus faecalis - growth & development
Enterococcus faecalis - metabolism
Ethanolamine
Ethanolamine - metabolism
Gastrointestinal tract
Gene Deletion
Gene expression
Gene Expression Regulation, Bacterial
Genes
Genes, Regulator
Genetic Complementation Test
Operons
Opportunist infection
Organic chemistry
Predictive control
Promoters
Protein A
Proteins
Ribonucleic acid
RNA
Structural proteins
Target recognition
Utilization
Title Ethanolamine Utilization and Bacterial Microcompartment Formation Are Subject to Carbon Catabolite Repression
URI https://www.ncbi.nlm.nih.gov/pubmed/30833356
https://www.proquest.com/docview/2232000723
https://www.proquest.com/docview/2188207457
https://pubmed.ncbi.nlm.nih.gov/PMC6482927
Volume 201
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVAFT
  databaseName: Open Access Digital Library
  customDbUrl:
  eissn: 1098-5530
  dateEnd: 99991231
  omitProxy: true
  ssIdentifier: ssj0014452
  issn: 0021-9193
  databaseCode: KQ8
  dateStart: 19160101
  isFulltext: true
  titleUrlDefault: http://grweb.coalliance.org/oadl/oadl.html
  providerName: Colorado Alliance of Research Libraries
– providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1098-5530
  dateEnd: 20250330
  omitProxy: true
  ssIdentifier: ssj0014452
  issn: 0021-9193
  databaseCode: DIK
  dateStart: 19160101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVFQY
  databaseName: GFMER Free Medical Journals
  customDbUrl:
  eissn: 1098-5530
  dateEnd: 20250330
  omitProxy: true
  ssIdentifier: ssj0014452
  issn: 0021-9193
  databaseCode: GX1
  dateStart: 19160101
  isFulltext: true
  titleUrlDefault: http://www.gfmer.ch/Medical_journals/Free_medical.php
  providerName: Geneva Foundation for Medical Education and Research
– providerCode: PRVAQN
  databaseName: PubMed Central
  customDbUrl:
  eissn: 1098-5530
  dateEnd: 20240930
  omitProxy: true
  ssIdentifier: ssj0014452
  issn: 0021-9193
  databaseCode: RPM
  dateStart: 19160101
  isFulltext: true
  titleUrlDefault: https://www.ncbi.nlm.nih.gov/pmc/
  providerName: National Library of Medicine
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELbKEBIviN8UBjLSxAMoI3Fqx3lcq3ZT2cZLK_UtshNHTGqTUVIk-J_4H7mLnTQdBQEvUWVbjeX7cr6z77sj5CjLdawjvDME_e8NchZ7MtPcS2PNcb8zss5bcHEpzuaD6YIver0fnailTaWP0-97eSX_I1VoA7kiS_YfJNv-KTTAb5AvPEHC8PwrGY_x3Bt80xWaivPqaulIlfWNwNDmYUbuLQbd2WBzG1M-aRiL707WBnUHHsagFTpSaw2tI1UBNpCdjAa6jZQtfmPGavuandP5D-qrWjqqGeiPU7Wp1KqN9DFa20sRLLJbts1l2bC_mhP9bTDjaL2pD7ovzBKAolyHO6xAfhT3LF2zww9AxdUJSa0XQXfm2dAMAtDEtnzisbHaGZOfYp2jrvpm7jDE4dTvaONg_x7BkPcwHWLWdAzMk9utsLn-v_yYTObn58lsvJi9uf7sYZEyvMx3FVtukdssEgILZpwu2ogicE25S05vZ-7ooPC-95237RpAv3g1N4NzO9bO7D655-RLTyzmHpCeKR6SO7Zw6bdHZNVFHu0gjwLyaIs8ehN5tEUe_LWhDnm0KqlFHt0ij26R95jMJ-PZ6MxzhTu8dODHlRezFOzeDJ2DLORSSm5kaFQA3oCf54znPs9MGjARigx2ucCEIgVbX-fgHg9ykYdPyEFRFuYZoVzmIkpVygR0KZZr5oc8hTU1gdEyFn3ytlnNJHVZ7bG4yjKpvVsmk-kwqZc-CWSfHLWDr20yl_3DDhuxJO5r_5KAGY2stoiFffK67QZdjBdsqjDlBsYE4K-CTc6jPnlqpdi-JwRfJww5TDjakW87APO87_YUV5_qfO9iIFnMoud_ntYLcnf7xR2Sg2q9MS_BYK70qxqmPwEaZMd5
linkProvider Geneva Foundation for Medical Education and Research
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ethanolamine+Utilization+and+Bacterial+Microcompartment+Formation+Are+Subject+to+Carbon+Catabolite+Repression&rft.jtitle=Journal+of+bacteriology&rft.au=Kaval%2C+Karan+Gautam&rft.au=Gebbie%2C+Margo&rft.au=Goodson%2C+Jonathan+R&rft.au=Cruz%2C+Melissa+R&rft.date=2019-05-15&rft.pub=American+Society+for+Microbiology&rft.issn=0021-9193&rft.eissn=1098-5530&rft.volume=201&rft.issue=10&rft.spage=1&rft_id=info:doi/10.1128%2FJB.00703-18&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-9193&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-9193&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-9193&client=summon